Placental transcriptomic signatures of prenatal exposure to Hydroxy-Polycyclic aromatic hydrocarbons. (February 2023)

• Record Type: Journal Article
• Authors: Paquette, Alison G.; Lapehn, Samantha; Freije, Sophie; MacDonald, James; Bammler, Theo; Day, Drew B.; Loftus, Christine T.; Kannan, Kurunthachalam; Alex Mason, W.; Bush, Nicole R.; LeWinn, Kaja Z; Enquobahrie, Daniel A.; Marsit, Carmen; Sathyanarayana, Sheela
• Is Part Of: Environment international. Volume 172(2023)
• Publication Date: 2023-02
• Subjects: Polycyclic aromatic hydrocarbons -- Placenta -- Transcriptomics -- Developmental origins of health and disease -- TRIP13; Environmental protection -- Periodicals; Environmental health -- Periodicals; Environmental monitoring -- Periodicals; Environmental Monitoring -- Periodicals; Environnement -- Protection -- Périodiques; Hygiène du milieu -- Périodiques; Environnement -- Surveillance -- Périodiques; Environmental health; Environmental monitoring; Environmental protection; Periodicals; 333.705
• DOI: 10.1016/j.envint.2023.107763
• Languages: English
• ISSNs: 0160-4120

Abstract

Highlights: Maternal urinary OH-PAH metabolites are associated with the placental transcriptome. This novel analysis was conducted in a large (N = 629) and diverse pregnancy cohort. TRIP13 was associated with phenanthrene metabolites and was validated in vitro . Vitamin absorption/digestion related genes were positively correlated with OH-PAHs. Female placentas had more genes whose expression was associated with OH-PAHs. Abstract: Background: Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous pollutants originating from petrogenic and pyrogenic sources. PAH compounds can cross the placenta, and prenatal PAH exposure is linked to adverse infant and childhood health outcomes. Objective: In this first human transcriptomic assessment of PAHs in the placenta, we examined associations between prenatal PAH exposure and placental gene expression to gain insight into mechanisms by which PAHs may disrupt placental function. Methods: The ECHO PATHWAYS Consortium quantified prenatal PAH exposure and the placental transcriptome from 629 pregnant participants enrolled in the CANDLE study. Concentrations of 12 monohydroxy-PAH (OH-PAH) metabolites were measured in mid-pregnancy urine using high performance liquid chromatography tandem mass spectrometry. Placental transcriptomic data were obtained using paired-end RNA sequencing. Linear models were fitted to estimate covariate-adjusted associations between maternal urinary OH-PAHs and placental gene expression. We performed sex-stratified analyses to evaluate whether associations varied by fetal sex. Selected PAH/gene expression analyses were validated by treating HTR-8/SVneo cells with phenanthrene, and quantifying expression via qPCR. Results: Urinary concentrations of 6 OH-PAHs were associated with placental expression of 8 genes. Three biological pathways were associated with 4 OH-PAHs. Placental expression of SGF29 and TRIP13 as well as the vitamin digestion and absorption pathway were positively associated with multiple metabolites. HTR-8/SVneo cells treated with phenanthrene also exhibited 23 % increased TRIP13 expression compared to vehicle controls (p = 0.04). Fetal sex may modify the relationship between prenatal OH-PAHs and placental gene expression, as more associations were identified in females than males (45 vs 28 associations). Discussion: Our study highlights novel genes whose placental expression may be disrupted by OH-PAHs. Increased expression of DNA damage repair gene TRIP13 may represent a response to double-stranded DNA breaks. Increased expression of genes involved in vitamin digestion and metabolism may reflect dietary exposures or represent a compensatory mechanism to combat damage related to OH-PAH toxicity. Further work is needed to study the role of these genes in placental function and their links to perinatal outcomes and lifelong health.